Skip to content

Children: Anxiety Disorders

Join a Research Study: Anxiety Disorders

Pediatric Anxiety Seminar: Coping Strategies for Anxious Kids, Ages 8-17, What Parents Need to Know

Thursday, October 16, 2014, 7 – 8:30pm

Presenter: Erin D. Berman, Ph.D. Clinical Psychologist, NIMH

Topics Include: 

  • How to identify an anxious child;
  • How to change anxious thinking;
  • The science and biological roots of anxiety in children;
  • How computer technology is transforming the understanding of anxiety;
  • Current treatment options (medications & CBT: cognitive behavioral therapy).

Seminar Location: Johns Hopkins University, Montgomery County Campus

A&R Building, Room106/8/10

9601 Medical Center Drive, Rockville, MD 20850

Enter Campus via Broschart Road 

To find out if you qualify, email NIMH or call 1-301-402-8225.

Join a Research Study: Anxiety Disorders, Depression

Pediatric Mood and Anxiety Research

This pediatric research study seeks to learn how the brain functions in children and adolescents with anxiety and/or depression. These studies seek boys and girls ages 8-17 to participate in research at the NIH Clinical Center in Bethesda, Maryland. Research participation includes brain imaging and computer-based problem solving and memory tasks. Treatment is available over 8 weeks of outpatient visits.

All participants will receive interviews to assess how they are doing in general, including his or her general mood, degree of nervousness and behavior. Each participant and one of his or her parents will be interviewed separately and together. All those enrolled in the study will have a physical examination. They will undergo tests involving problem-solving and memory and perform tasks that involve looking at pictures, remembering things, testing reaction times, and making simple choices.

Participants with anxiety or depression will first meet with a psychiatrist or psychologist for two weekly sessions of talk therapy. Those who remain anxious or depressed after these 2 weeks will have the 3 options based on their choice: 1) treatment with fluoxetine daily for 8 weeks 2) cognitive-behavioral therapy (a talk therapy) once a week for 8 weeks 3) a random assignment (50% chance) to either placebo or fluoxetine for 8 weeks. All participants will be seen approximately weekly for 8 weeks by a doctor to talk and complete verbal and written exercises. Blood samples will be drawn for laboratory tests before drug treatment and after it ends.

Those who have not improved by the end of the study will be offered other treatment for 1 to 3 months, and the clinicians will help with finding subsequent aftercare. Those who improve with treatment will continue therapy at NIH until an outside physician is able to assume responsibility for monitoring medication.

To find out if you qualify, email NIMH or call 1-301-402-8225 [TTY: 1-866-411-1010].